Groups/Patients | Baseline | After | 24-wk | |||||
---|---|---|---|---|---|---|---|---|
e’ | E/e’ | E/A | LVDD | e’ | E/e’ | E/A | LVDD | |
SITA 1 | 7.0 | 10.1 | 0.9 | II | 7.0 | 2.9 | 0,5 | I |
2 | 7.0 | 5.1 | 0.6 | I | 11.0 | 4.7 | 0,6 | 0 |
3 | 8.0 | 9.5 | 0.7 | 0 | 10.0 | 5.7 | 0,6 | 0 |
4 | 7.0 | 7.6 | 0.9 | I | 9.9 | 9.8 | 1.1 | 0 |
5 | 6.0 | 9.7 | 1.8 | II | 9.1 | 8.2 | 2.0 | 0 |
6 | 7.4 | 7.2 | 1.1 | I | 7.0 | 6.3 | 0.8 | I |
7 | 8.0 | 8.1 | 1.0 | 0 | 9.0 | 10.0 | 1.0 | 0 |
8 | 8.0 | 4.3 | 0.6 | 0 | 6.8 | 5.9 | 0.6 | I |
9 | 10.0 | 6.3 | 0.8 | 0 | 8.0 | 8.4 | 1.5 | 0 |
10 | 15.0 | 6.0 | 0.8 | 0 | 7.0 | 10.4 | 0.7 | I |
11 | 7.0 | 11.1 | 0.9 | II | 8.0 | 8.8 | 1.0 | 0 |
12 | 10.0 | 5.6 | 0.7 | 0 | 8.0 | 8.1 | 0.8 | 0 |
13 | 4.7 | 12.1 | 0.8 | II | 6.1 | 6.6 | 0.5 | I |
14 | 10.0 | 6.1 | 0.9 | 0 | 6.4 | 7.5 | 0.7 | I |
15 | 7.0 | 10.0 | 1.1 | I | 5.8 | 12.8 | 0.9 | I |
NPH 1 | 7.0 | 12.0 | 0.9 | II | 7.0 | 13.3 | 1.2 | II |
2 | 6.0 | 9.8 | 0.7 | II | 5.2 | 12.0 | 0.6 | II |
3 | 7.0 | 5.7 | 0.6 | I | 7.0 | 4.7 | 0.5 | I |
4 | 6.0 | 9.8 | 0.9 | II | 10.0 | 9.2 | 1.7 | 0 |
5 | 4.0 | 16.5 | 0.9 | II | 5.0 | 12.4 | 0.7 | II |
6 | 8.0 | 5.3 | 0.7 | 0 | 9.0 | 5.3 | 0.7 | 0 |
7 | 10.0 | 7.3 | 1.0 | 0 | 10.0 | 6.0 | 0.9 | 0 |
8 | 18.0 | 2.8 | 0.7 | 0 | 8.8 | 6.6 | 0.7 | 0 |
9 | 6.1 | 12.1 | 0.9 | I | 7.5 | 10.0 | 0.8 | II |
10 | 10.0 | 6.8 | 0.9 | 0 | 6.3 | 11.4 | 0.8 | II |
11 | 4.6 | 12.0 | 0.6 | II | 6.0 | 10.8 | 0.8 | II |
12 | 7.1 | 7.7 | 0.9 | I | 7.9 | 10.0 | 1.3 | I |
13 | 5.0 | 13.6 | 0.7 | I | 4,2 | 16.2 | 0.6 | I |
14 | 8.0 | 14.2 | 1.2 | 0 | 9.0 | 10.0 | 1.0 | 0 |